Quantcast

Latest Staphylococcaceae Stories

2014-03-19 12:22:44

Clearstream, LLC warns of athletes' increased risk of contracting MRSA due to the bacterium's tendency to target crowded areas with lenient hygiene. Clearstream is advancing antimicrobial technology that actively provides long-term protection without the use of poisons--which no other antimicrobial currently offers. HARRISBURG, N.C., March 19, 2014 /PRNewswire-iReach/ -- Outbreaks of MRSA were once confined to healthcare facilities, but now the bacterium is commonly found in sports...

2014-03-18 12:31:11

WOBURN, Mass., March 18, 2014 /PRNewswire/ -- AdvanDx today announced that it has submitted to the U.S. Food and Drug Administration for 510(k) clearance its new mecA XpressFISH(TM) test for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) from S. aureus positive blood cultures. This assay will provide physicians with a new way to rapidly identify MRSA enabling them to implement appropriate treatment for patients with bloodstream infections....

2014-03-13 12:29:08

Findings from large study of hip and knee surgical site infections published in The Journal of Arthroplasty GREENSBORO, N.C., March 13, 2014 /PRNewswire/ -- A large study of infections following knee and hip replacement surgery found that the use of AQUACEL(®) Ag SURGICAL cover dressing reduced post-operative joint infections by 76 percent, which study investigators estimate could save the U.S. healthcare system $375 million annually. Study results were published in The Journal of...

Doctors Issue New Treatment Guidelines For Skin Abscesses Caused By Methicillin-resistant Staphylococcus Aureus
2014-03-13 11:59:37

Rachel Champeau, UCLA It has been more than 10 years since the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), and doctors are still grappling with how to diagnose, treat and prevent this virulent form of staph infection, which is immune to many antibiotics. As MRSA cases have increased dramatically over the decade, so have the number of skin abscesses — generally pus-filled boils or pimples with discharge — that characterize these...

New Research Could Help Develop Bacteria-resistant Materials
2014-03-04 14:23:46

Dan Krotz, Berkeley Lab The bacterium Staphylococcus Aureus (S. aureus) is a common source of infections that occur after surgeries involving prosthetic joints and artificial heart valves. The grape-shaped microorganism adheres to medical equipment, and if it gets inside the body, it can cause a serious and even life-threatening illness called a Staph infection. The recent discovery of drug-resistant strains of S. aureus makes matters even worse. A Staph infection can’t start unless...

2014-02-21 12:24:15

The Law Firm of Jonathan C. Reiter offers information about the legal rights of those who contract MRSA during a hospital stay. NEW YORK, Feb. 21, 2014 /PRNewswire-iReach/ -- Hospitals are required to take steps to maintain a safe and healthy environment for patients and visitors. When they fail to do so patient exposure to illness and infection often results. One of the most problematic occurrences faced by many patients in a hospital setting is the risk of contracting MRSA. MRSA is...

2014-02-20 23:26:56

New research focuses on skin bacteria as a major factor in the rapid spread of MRSA. Grime Busters explains how a collegiate hockey venue is having success in battling the germs associated with the disease through the use of a bacteria-killing product. Gaylord, MI (PRWEB) February 20, 2014 The latest research on the MRSA skin disease, published by the American Society for Microbiology, holds important information for everyone who is trying to kill the germs that spread bacteria-related...

2014-02-19 08:31:18

SAN DIEGO, Feb. 19, 2014 /PRNewswire/ -- CURx Pharmaceuticals today announced it has entered into a global license agreement with Gilead Sciences, Inc. for development of Fosfomycin:Tobramycin for Inhalation (FTI) to treat Pseudomonas aeruginosa lung infection in cystic fibrosis (CF) patients. FTI is ready for Phase III clinical trials, having successfully completed a Phase II trial in CF patients. (Logo: http://photos.prnewswire.com/prnh/20140212/MM64137LOGO) "This is a great...

2014-02-11 08:33:36

LAUSANNE, Switzerland, February 11, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, and Affinium Pharmaceuticals (Affinium), a Canadian company focusing on the development of a platform of novel, targeted narrow-spectrum antibacterial therapeutics, today announced the acquisition by Debiopharm of Affinium's clinical and...

2014-02-07 13:09:09

Production of an exceptionally large surface protein prevents bacteria from forming clumps and reduces their ability to cause disease A genetic mechanism that controls the production of a large spike-like protein on the surface of Staphylococcus aureus (staph) bacteria alters the ability of the bacteria to form clumps and to cause disease, according to a new University of Iowa study. The new study is the first to link this genetic mechanism to the production of the giant surface protein...


Latest Staphylococcaceae Reference Libraries

0_565be8ac4669df235cfa9eb09fa14a3d
2011-04-26 20:59:00

Staphylococcus epidermidis is one of thirty-three known species belonging to the genus Staphylococcus. It is part of our skin flora and can also be found in the mucous membranes and in animals. It is the most common species found in laboratory test due to contamination. It is not usually pathogenic; however, patients with a compromised immune system often risk infection. Infections can be both nosocomial and community acquired and are more of a threat to hospital patients. Hospitals carry...

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

More Articles (2 articles) »
Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related